Target intelligence / Profile preview

MicroRNA 4512 (miR-4512)

Target
miR-4512
Molecular classification
MicroRNA, Non-coding RNA, Regulatory RNA
01

Overview

MicroRNA 4512 is a small non-coding RNA molecule of the microRNA class, primarily identified as a human regulatory RNA (hsa-miR-4512). It functions in the post-transcriptional regulation of gene expression, with a specific role in modulating innate immune responses. In systemic lupus erythematosus (SLE), miR-4512 is downregulated in monocytes and macrophages, which leads to increased expression of pro-inflammatory mediators such as TLR4 and CXCL2, thereby promoting cytokine secretion and neutrophil extracellular trap (NET) formation—a process implicated in SLE pathogenesis. miR-4512 acts by directly targeting the mRNAs of TLR4 and CXCL2, suppressing their translation. The abnormal regulation of this microRNA is associated with autoimmune and inflammatory mechanisms, primarily within the context of SLE pathophysiology. While no currently approved drugs interact directly with miR-4512, it is considered a novel therapeutic target and a potential biomarker for autoimmune activity and treatment response monitoring in SLE[2].

Other names
MIR4512hsa-mir-4512miR-4512microRNA-4512
02

Mechanism of action

Not applicable for small molecule drugs; miR-4512 itself targets mRNAs (notably TLR4 and CXCL2) to repress their expression[2]

03

Biological functions

Regulation of innate immune responseSuppression of pro-inflammatory cytokine secretion in monocytes and macrophagesNegative regulation of TLR4 (Toll-like receptor 4) pathwayInhibition of neutrophil activation and NETosis
04

Disease associations

Systemic lupus erythematosus (SLE)Autoimmune disease (innate immune dysregulation)Inflammatory response
05

Safety considerations

Potential off-target effects or immune dysregulation if manipulated therapeutically (inferred from microRNA biology and involvement in multiple regulatory networks; not directly stated in sources)
06

Biomarkers

Decreased miR-4512 levels in monocytes and macrophages in SLE patientsElevated CXCL2 and TLR4 expression in cases of reduced miR-4512NETosis markers (such as cfDNA, MPO, NE) indicative of miR-4512 downregulation effect in SLE[2]

Beyond the preview

Go deeper on MicroRNA 4512 (miR-4512).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 4512 (miR-4512).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call